Bone Metastases in Medulloblastoma –Single Institution Experience

REFERENCES

• Boldwin RT, Preston-Martin S. Epidemiology of brain tumors in childhood: a review. Toxicol Appl Pharmacol. 2004;99:118–131.
   Google Scholar
• Varan A, Sari N, Akalan N, Extraneural metastasis in intracranial tumors in children: the experience of a single center. J Neurooncol. 2006; 79:187–190.
   PubMedGoogle Scholar
• Blooom HJ. Medulloblastoma in children: increasing survival rates and further prospects. Int J Radiat Oncol Biol Phys. 1982;8:2023–2027.
   PubMedGoogle Scholar
• Friedman HS, Mahaley MS Jr, Schold SC Jr Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma. Neurosurgery. 1986;18:335–340.
   PubMedGoogle Scholar
• Campbell AN, Chan HS, Becker LE, Extracranial metastases in childhood primary intracranial tumors. A report of 21 cases and review of the literature. Cancer. 1984;53:974–981.
   PubMedGoogle Scholar
• Tarbell NJ, Loeffler JS, Silver B, The change in patterns of relapse in medulloblastoma. Cancer. 1991;68:1600–1604.
   PubMed Web of Science ®Google Scholar
• Sure U, Bertalanffu H, Isenmann S, Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients. Acta Neurochir. 1995;136:117–126.
   PubMedGoogle Scholar
• Bates T. Extracranial metastases from a cerebellar medulloblastoma. Proc R Soc Med. 1973;66: 652–654.
   PubMedGoogle Scholar
• Robertson LP. Advances in treatment of pediatric brain tumors. NeuroRx: J Am Soc Experimental Neurother. 2006;3:276–291.
   Google Scholar
• Nelson A. Metastases of intracranial tumors. Am J Cancer. 1936;28:1–12.
   Google Scholar
• Das S, Dalby JE. Distant metastases from medulloblastoma. Acta Radiol Ther Phys Biol. 1977;16: 117–123.
   PubMed Web of Science ®Google Scholar
• McComb JG, Davis RL, Isaacs H Jr. Extraneural metastatic medulloblastoma during childhood. Neurosurgery. 1981;9:548–551.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Roberts GJ, Lucas VS, Metastatic infiltration of the dental pulp by medulloblastoma. J Oral Pathol Med. 2002;31:244–245.
   PubMedGoogle Scholar
• Kleinman GM, Hochberg FH, Richardson EP Jr. Systemic metastases from medulloblastoma: report of two cases and review of the literature. Cancer. 1981;48:2296–2309.
   PubMed Web of Science ®Google Scholar
• Akyuz C, Yalcin B, Kutluk T, Brief report: medulloblastoma with widespread skeletal metastases presenting with hypercalcemia. Med Pediatr Oncol. 1999;33:126–128.
   PubMedGoogle Scholar
• Eberhart CG, Cohen KJ, Tihan T, Medulloblastoma with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol. 2003;25:198–203.
   PubMedGoogle Scholar
• Vieco PT, Azouz EM, Hoeffel JC. Metastases to bone in medulloblastoma. A report of five cases. Skeletal Radiol. 1989;18:445–449.
   PubMedGoogle Scholar
• Leo E, Schlegel PG, Lindemann A. Chemotherapeutic induction of long-term remission in metastatic medulloblastoma. J Neurooncol. 1997;32:149–154.
   PubMedGoogle Scholar
• Paulino AC. Long-term survival in a child with extraneural metastasis from medulloblastom treated with chemo-radiotherapy. Med Pediatr Oncol. 2003;40:396–397.
   PubMedGoogle Scholar
• Liwnicz BH, Rubinstein LJ. The pathways of extraneural spread in metastasizing gliomas: A report of three cases and critical review of the literature. Hum Pathol. 1979;10:453–467.
   PubMed Web of Science ®Google Scholar
• Choux M, Lena G, Alfonsi S, Le médulloblastome [Medulloblastoma]. Neurochirurgie [Neurosurgery]. 1982;28(Suppl 1):162.
   Google Scholar
• Nikitović M, Golubičić I, Pekmezović T, Outcome of childhood brain tumors in Serbia. J BUON. 2011;16:290–296.
   PubMedGoogle Scholar
• Bach M, Simpson WJ, Platts ME. Metastatic cerebellar sarcoma (desmoplastic medulloblastoma) with diffuse osteosclerosis and leukoerythroblastic anemia. AJR. 1968;103:38.
   Google Scholar
• Black SPW, Keats TE. Generalized osteosclerosis secondary to metastatic medulloblastoma of the cerebellum. Radiology. 1964;82:395.
   PubMedGoogle Scholar
• Booher KR, Schmidtknecht TM. Cerebellar medulloblastoma with skeletal metastases: case report and review of the literature. J Bone Joint Surg. 1977;59:684–686.
   PubMedGoogle Scholar
• Makeever LC, King JD. Medulloblastoma with extracranial metastasis through a ventriculovenous shunt. Am J Clin Pathol. 1966;46:245–249.
   PubMed Web of Science ®Google Scholar
• Mazloom A, Zangeneh HA, Paulino CA. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncology Biol Phys. 2010;78:72–78.
   PubMed Web of Science ®Google Scholar
• Karajannis M, Allen JC, Newcomb EW Treatment of pediatric brain tumors. J Cell Physiol. 2008;217:584–589.
   PubMedGoogle Scholar
• Rochkind S, Blatt I, Sadeh M, Extracranial metastases of medulloblastoma in adults: literature review. J Neurol Neurosurg Psychiatry. 1991;54:80–86.
   PubMed Web of Science ®Google Scholar
• Barai S, Bandopadhayaya GP, Julka PK, Cerebellar medulloblastoma presenting with skeletal metastasis. J Postgrad Med. 2004;50:110–112.
   PubMedGoogle Scholar
• Chamberlain MC, Silver P, Edwards MS, et al. Treatment of extraneural metastatic medulloblastoma with a combination of cyclophosphamide, adriamycin and vincristine. Neurosurgery. 1988;23:476–479.
   PubMedGoogle Scholar
• Mahoney DH, Steuber CP, Sandbach JF, et al. Extraneural metastases from medulloblastoma: long term survival after sequentially scheduled chemotherapy and radiotherapy. Med Pediatr Oncol. 1986;14:329–331.
   PubMedGoogle Scholar
• Zia MI, Forsyth P, Chaudhry A, et al. Possible benefits of high-dose chemotherapy and autologous stem cell transplatation for adults with recurrent medulloblastoma. Bone Marrow Transplant. 2002;30:565–569.
   PubMedGoogle Scholar
• Dunkel IJ, Boyett JM, Yates A, High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma children's cancer group. J Clin Oncol. 1998;16:222–228.
   PubMed Web of Science ®Google Scholar
• Lundberg HJ, Weissman ED, Beatty AP, Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogenic bone marrow transplantation. J Neuro-Oncol. 1992;13:51–155.
   Google Scholar
• Tabori U, Sung L, Hukin J, Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys. 2006;64:402–407.
   PubMed Web of Science ®Google Scholar
• Fernandez-Teijeiro A, Betensky RA, Sturla IM, Combining gene expression profiles and other profiles and clinical parameters for risk stratification in medulloblastomas. J Clin Oncol. 2004;22:994–998.
   PubMedGoogle Scholar
• Gajjar A, Herman R, Kocak M, Clinical, histopathologic and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004;22:984–993.
   PubMed Web of Science ®Google Scholar
• Tabori U, Baskin B, Shago M, Universal poor survival in children with medulloblastoma harboring somatic TP53 mutation. J Clin Oncol. 2010;26:1325–1350.
   Google Scholar
• Pfister S, Remke M, Benner A, Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol. 2009;27:1627–1636.
   PubMed Web of Science ®Google Scholar
• Northcott AP, Korshunov A, Hendrik W, Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2011;29:1408–1414.
   PubMed Web of Science ®Google Scholar